Financial Ratios

HARLEYSTREET PHARMACEUTICALS LTD.

NSE : NABSE : 524082ISIN CODE : INE344K01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE27.000 (0 %)
PREV CLOSE ( ) 27.00
OPEN PRICE ( ) 27.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 300
TODAY'S LOW / HIGH ( )27.00 27.00
52 WK LOW / HIGH ( ) 2727
NSE
This Company is not listed in NSE
Select year
ParticularsMar2010Mar2009Mar2008Mar2007Mar2006
Operational & Financial Ratios
   Earnings Per Share (Rs)5.573.653.275.455.95
   CEPS(Rs)10.378.527.959.5410.10
   DPS(Rs)1.000.000.000.000.00
   Book NAV/Share(Rs)35.9931.5827.9324.6719.22
   Tax Rate(%)29.7928.3435.1236.0830.56
Margin Ratios
   Core EBITDA Margin(%)19.8221.70-212.50-151.33-119.97
   EBIT Margin(%)12.9812.3262.9075.2166.13
   Pre Tax Margin(%)12.9510.6754.9670.2358.93
   PAT Margin (%)9.097.6535.6644.8940.92
   Cash Profit Margin (%)16.9217.8686.7378.6569.43
Performance Ratios
   ROA(%)9.866.926.9212.9415.45
   ROE(%)16.4912.2612.4224.8136.65
   ROCE(%)23.4318.2717.7930.7134.30
   Asset Turnover(x)1.080.910.190.290.38
   Sales/Fixed Asset(x)0.890.730.150.230.31
   Working Capital/Sales(x)28.60-10.65-2.56-17.45-5.74
Efficiency Ratios
   Fixed Capital/Sales(x)1.121.386.494.273.25
   Receivable days11.6011.4748.9029.2930.36
   Inventory Days17.3020.2094.4757.6035.57
   Payable days494.56693.921555.712313.201103.70
Valuation Parameters
   PER(x)2.170.000.000.000.00
   PCE(x)1.170.000.000.000.00
   Price/Book(x)0.340.000.000.000.00
   Yield(%)8.26
   EV/Net Sales(x)0.160.151.151.321.76
   EV/Core EBITDA(x)0.750.671.011.051.11
   EV/EBIT(x)1.211.231.831.511.59
   EV/CE(x)0.170.130.220.300.40
   M Cap / Sales0.200.000.000.000.00
Growth Ratio
   Net Sales Growth(%)26.20415.69-12.6920.3315.47
   Core EBITDA Growth(%)18.642.96-21.02-4.0147.83
   EBIT Growth(%)35.302.00-36.84-5.1968.27
   PAT Growth(%)52.6811.66-40.00-8.55102.64
   EPS Growth(%)52.6811.66-40.00-8.55102.64
Financial Stability Ratios
   Total Debt/Equity(x)0.000.010.160.310.41
   Current Ratio(x)1.120.810.740.940.73
   Quick Ratio(x)0.970.680.580.730.58
   Interest Cover(x)424.167.477.9315.109.18
   Total Debt/Mcap(x)0.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.